RAPP vs RDY

Rapport Therapeutics, Inc. vs Dr. Reddy's Laboratories Ltd — Valuation Comparison 2026

RAPP

Pharmaceutical Preparations
Rapport Therapeutics, Inc.
Quality
4.2
out of 10
Value Trap
12
SAFE
Price
$39.50
Last close
Models
8/13
Active
VS

RDY

Pharmaceutical Preparations
Dr. Reddy's Laboratories Ltd
Quality
9.0
out of 10
Value Trap
18
SAFE
Price
$13.63
Last close
Models
13/13
Active

Model-by-Model Comparison

ModelType RAPP Fair ValueRAPP Upside RDY Fair ValueRDY Upside
Bayesian DCF Intrinsic $10.45 -73.6% $3.00 -78.0%
Earnings Power Value Intrinsic — — $7.14 -47.6%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $3.95 -90.0% $14.37 +5.5%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for RAPP vs RDY — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

RAPP vs RDY — Which Stock Is More Undervalued?

RDY scores higher with a 9.0/10 quality rating vs RAPP's 4.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Rapport Therapeutics, Inc. (RAPP) and Dr. Reddy's Laboratories Ltd (RDY) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

RAPP currently trades at $39.50 with a QOC of 4.2/10, while RDY trades at $13.63 with a QOC of 9.0/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).

RAPP
View Full Rapport Therapeutics, Inc. Analysis →
RDY
View Full Dr. Reddy's Laboratories Ltd Analysis →